SC
MRK icon

Stralem & Co’s Merck MRK Stock Holding History

Stralem & Co’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$4.22M Sell
57,217
-649
-1% -$48.9K 2.69% 19
2020
Q1 		$4.25M Buy
57,866
+220
+0.4% +$17.3K 3.15% 13
2019
Q4 		$5M Sell
57,646
-18,414
-24% -$1.51M 2.8% 22
2019
Q3 		$6.11M Sell
76,060
-2,358
-3% -$189K 3.53% 7
2019
Q2 		$6.27M Sell
78,418
-14,897
-16% -$1.14M 3.41% 10
2019
Q1 		$7.41M Buy
93,315
+7,001
+8% +$524K 3.39% 6
2018
Q4 		$6.29M Sell
86,314
-78,967
-48% -$5.57M 3% 15
2018
Q3 		$11.2M Sell
165,281
-16,244
-9% -$1.03M 3.32% 5
2018
Q2 		$10.5M Sell
181,525
-110,578
-38% -$6.24M 3.1% 12
2018
Q1 		$15.2M Sell
292,103
-39,153
-12% -$2.11M 3.02% 18
2017
Q4 		$17.8M Buy
331,256
+8,431
+3% +$467K 3.02% 18
2017
Q3 		$19.7M Sell
322,825
-82,477
-20% -$5M 2.84% 20
2017
Q2 		$24.8M Sell
405,302
-4,559
-1% -$278K 2.9% 21
2017
Q1 		$24.9M Sell
409,861
-13,874
-3% -$842K 2.91% 22
2016
Q4 		$23.8M Sell
423,735
-30,360
-7% -$1.78M 2.83% 24
2016
Q3 		$27M Sell
454,095
-3,616
-0.8% -$211K 3.13% 7
2016
Q2 		$25.2M Sell
457,711
-41,920
-8% -$2.23M 2.9% 15
2016
Q1 		$25.2M Sell
499,631
-45,007
-8% -$2.2M 2.76% 20
2015
Q4 		$27.4M Sell
544,638
-160,529
-23% -$8.09M 2.78% 23
2015
Q3 		$33.2M Sell
705,167
-89,501
-11% -$4.75M 2.76% 20
2015
Q2 		$43.2M Sell
794,668
-192,674
-20% -$10.8M 2.96% 17
2015
Q1 		$54.2M Sell
987,342
-155,712
-14% -$8.82M 3.02% 15
2014
Q4 		$61.9M Sell
1,143,054
-178,890
-14% -$9.97M 2.88% 19
2014
Q3 		$74.8M Sell
1,321,944
-558,102
-30% -$31.3M 3.01% 19
2014
Q2 		$104M Sell
1,880,046
-230,275
-11% -$12.6M 3.54% 11
2014
Q1 		$114M Sell
2,110,321
-196,763
-9% -$10.2M 3.61% 8
2013
Q4 		$110M Sell
2,307,084
-190,736
-8% -$8.72M 3.3% 17
2013
Q3 		$113M Sell
2,497,820
-114,723
-4% -$5.24M 3.46% 13
2013
Q2 		$116M Buy
+2,612,543
New +$117M 3.5% 8

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Stralem & Co's MRK Position: Q2 2020 in Review

Stralem & Co reduced its Merck (MRK) stake by 1.1% in Q2 2020, selling an estimated $48.9K and leaving 57,217 shares worth $4.22M. The position accounts for 2.69% of the portfolio, ranked #19.

Stralem & Co first reported a position in MRK in Q2 2013 and has held it in 29 quarters since. The position peaked at $116M in Q2 2013. 2,496 funds tracked by Wall St. Rank hold MRK as of Q2 2020.

  • Stralem & Co held 57,217 shares of Merck worth $4.22M as of Q2 2020.
  • Stralem & Co sold 649 Merck shares in Q2 2020, an estimated $48.9K.
  • Merck made up 2.69% of Stralem & Co's portfolio in Q2 2020, its #19 holding.
  • Stralem & Co first reported a position in Merck in Q2 2013 and has held it in 29 quarters since.
  • Stralem & Co's Merck position peaked at $116M in Q2 2013.
  • 2,496 funds tracked by Wall St. Rank held Merck as of Q2 2020.

Based on Stralem & Co's 13F filing for Q2 2020, filed 20 Jul 2020.